NASDAQ:SCPH - Scpharmaceuticals Stock Price, Price Target & More

$10.19 -0.56 (-5.21 %)
(As of 04/23/2018 07:54 AM ET)
Previous Close$10.75
Today's Range$10.12 - $11.00
52-Week Range$10.12 - $18.17
Volume92,700 shs
Average Volume57,012 shs
Market Capitalization$188.87 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Scpharmaceuticals (NASDAQ:SCPH)

Scpharmaceuticals logoscPharmaceuticals Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products. The company's under development products are for heart failure and infectious diseases that include Furoscix for the treatment of worsening or decompensated heart failure outside of the inpatient setting. in March 2014. The company was founded in 2013 and is based in Burlington, Massachusetts.

Receive SCPH News and Ratings via Email

Sign-up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SCPH
CUSIPN/A
Phone617-517-0730

Debt

Debt-to-Equity Ratio0.09%
Current Ratio24.12%
Quick Ratio24.12%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$6.02 per share
Price / Book1.69

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees29
Outstanding Shares18,530,000

How to Become a New Pot Stock Millionaire

Scpharmaceuticals (NASDAQ:SCPH) Frequently Asked Questions

What is Scpharmaceuticals' stock symbol?

Scpharmaceuticals trades on the NASDAQ under the ticker symbol "SCPH."

How were Scpharmaceuticals' earnings last quarter?

Scpharmaceuticals Inc (NASDAQ:SCPH) posted its quarterly earnings data on Tuesday, March, 20th. The company reported ($0.80) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.53) by $0.27. View Scpharmaceuticals' Earnings History.

What price target have analysts set for SCPH?

3 equities research analysts have issued twelve-month price objectives for Scpharmaceuticals' stock. Their forecasts range from $20.00 to $26.00. On average, they expect Scpharmaceuticals' stock price to reach $23.3333 in the next year. View Analyst Ratings for Scpharmaceuticals.

Who are some of Scpharmaceuticals' key competitors?

Who are Scpharmaceuticals' key executives?

Scpharmaceuticals' management team includes the folowing people:
  • Mr. John H. Tucker, Pres, CEO & Director (Age 55)
  • Dr. Troy A. Ignelzi, Chief Financial Officer (Age 50)
  • Mr. Abraham Ceesay, Chief Operating Officer (Age 40)
  • Dr. Pieter Muntendam M.D., Consultant (Age 60)
  • Katherine Taudvin, Director of Corp. Devel.

When did Scpharmaceuticals IPO?

(SCPH) raised $96 million in an IPO on Friday, November 17th 2017. The company issued 6,400,000 shares at a price of $14.00-$16.00 per share. Jefferies, Leerink Partners and BMO Capital Markets served as the underwriters for the IPO.

When does Scpharmaceuticals' lock-up period expire?

Scpharmaceuticals' lock-up period expires on Wednesday, May 16th. Scpharmaceuticals had issued 6,400,000 shares in its public offering on November 17th. The total size of the offering was $89,600,000 based on an initial share price of $14.00. After the expiration of Scpharmaceuticals' lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Has Scpharmaceuticals been receiving favorable news coverage?

News stories about SCPH stock have been trending somewhat positive this week, according to Accern. The research firm identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Scpharmaceuticals earned a news sentiment score of 0.19 on Accern's scale. They also gave news stories about the company an impact score of 42.41 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of Scpharmaceuticals?

Shares of SCPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Scpharmaceuticals' stock price today?

One share of SCPH stock can currently be purchased for approximately $10.19.

How big of a company is Scpharmaceuticals?

Scpharmaceuticals has a market capitalization of $188.87 million. The company earns $-23,810,000.00 in net income (profit) each year or ($8.04) on an earnings per share basis. Scpharmaceuticals employs 29 workers across the globe.

How can I contact Scpharmaceuticals?

Scpharmaceuticals' mailing address is 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA, 01830. The company can be reached via phone at 617-517-0730 or via email at [email protected]


MarketBeat Community Rating for Scpharmaceuticals (SCPH)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  65
MarketBeat's community ratings are surveys of what our community members think about Scpharmaceuticals and other stocks. Vote "Outperform" if you believe SCPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SCPH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Scpharmaceuticals (NASDAQ:SCPH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Scpharmaceuticals in the last 12 months. Their average twelve-month price target is $23.3333, suggesting that the stock has a possible upside of 128.98%. The high price target for SCPH is $26.00 and the low price target for SCPH is $20.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $23.3333$23.3333$22.3333N/A
Price Target Upside: 128.98% upside75.04% upside49.69% upsideN/A

Scpharmaceuticals (NASDAQ:SCPH) Consensus Price Target History

Price Target History for Scpharmaceuticals (NASDAQ:SCPH)

Scpharmaceuticals (NASDAQ:SCPH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/21/2018Jefferies GroupReiterated RatingBuy$26.00HighView Rating Details
12/12/2017Leerink SwannInitiated CoverageOutperform -> Outperform$20.00MediumView Rating Details
12/12/2017BMO Capital MarketsInitiated CoverageOutperform$24.00MediumView Rating Details
(Data available from 4/23/2016 forward)

Earnings

Scpharmaceuticals (NASDAQ:SCPH) Earnings History and Estimates Chart

Earnings by Quarter for Scpharmaceuticals (NASDAQ:SCPH)

Scpharmaceuticals (NASDAQ:SCPH) Earnings Estimates

2018 EPS Consensus Estimate: ($3.03)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.52)($0.50)($0.51)
Q2 20182($0.63)($0.58)($0.61)
Q3 20182($1.33)($0.67)($1.00)
Q4 20182($0.97)($0.86)($0.92)

Scpharmaceuticals (NASDAQ SCPH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/20/2018Q4 2017($0.5270)($0.80)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Scpharmaceuticals (NASDAQ:SCPH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Scpharmaceuticals (NASDAQ SCPH) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 42.03%
Insider Trading History for Scpharmaceuticals (NASDAQ:SCPH)
Insider Trading History for Scpharmaceuticals (NASDAQ:SCPH)

Scpharmaceuticals (NASDAQ SCPH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/21/20175Am Partners Iv, LlcMajor ShareholderBuy654,762$14.00$9,166,668.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Scpharmaceuticals (NASDAQ SCPH) News Headlines

Source:
DateHeadline
Q1 2018 EPS Estimates for Scpharmaceuticals Inc Cut by Analyst (SCPH)Q1 2018 EPS Estimates for Scpharmaceuticals Inc Cut by Analyst (SCPH)
www.americanbankingnews.com - April 18 at 7:42 AM
Zacks: Scpharmaceuticals Inc (SCPH) Given $23.33 Consensus Price Target by BrokeragesZacks: Scpharmaceuticals Inc (SCPH) Given $23.33 Consensus Price Target by Brokerages
www.americanbankingnews.com - April 18 at 1:18 AM
Biotech Guru Samuel Isaly Bets on scPharmaceuticals (SCPH), Throws in the Towel on Synergy Pharmaceuticals (SGYP)Biotech Guru Samuel Isaly Bets on scPharmaceuticals (SCPH), Throws in the Towel on Synergy Pharmaceuticals (SGYP)
finance.yahoo.com - April 11 at 8:24 AM
-$0.51 EPS Expected for Scpharmaceuticals Inc (SCPH) This Quarter-$0.51 EPS Expected for Scpharmaceuticals Inc (SCPH) This Quarter
www.americanbankingnews.com - April 6 at 11:27 AM
Do Scpharmaceuticals (SCPH) and Rigel Pharmaceuticals (RIGL) Have Winning Catalysts Ahead? Analysts Say YesDo Scpharmaceuticals (SCPH) and Rigel Pharmaceuticals (RIGL) Have Winning Catalysts Ahead? Analysts Say Yes
finance.yahoo.com - April 4 at 4:18 PM
Analysts Anticipate Scpharmaceuticals Inc (SCPH) to Post ($0.51) EPSAnalysts Anticipate Scpharmaceuticals Inc (SCPH) to Post ($0.51) EPS
www.americanbankingnews.com - April 3 at 1:24 PM
Scpharmaceuticals (SCPH) Upgraded at Zacks Investment ResearchScpharmaceuticals (SCPH) Upgraded at Zacks Investment Research
www.americanbankingnews.com - March 28 at 10:48 AM
Leerink Swann Weighs in on Scpharmaceuticals Incs Q1 2018 Earnings (SCPH)Leerink Swann Weighs in on Scpharmaceuticals Inc's Q1 2018 Earnings (SCPH)
www.americanbankingnews.com - March 26 at 1:02 AM
FY2022 Earnings Estimate for Scpharmaceuticals Inc (SCPH) Issued By Leerink SwannFY2022 Earnings Estimate for Scpharmaceuticals Inc (SCPH) Issued By Leerink Swann
www.americanbankingnews.com - March 23 at 4:58 PM
Scpharmaceuticals Inc (SCPH) to Post FY2019 Earnings of ($2.36) Per Share, Jefferies Group ForecastsScpharmaceuticals Inc (SCPH) to Post FY2019 Earnings of ($2.36) Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - March 23 at 2:56 PM
Scpharmaceuticals (SCPH) Issues Quarterly  Earnings Results, Misses Estimates By $0.27 EPSScpharmaceuticals (SCPH) Issues Quarterly Earnings Results, Misses Estimates By $0.27 EPS
www.americanbankingnews.com - March 22 at 11:50 PM
Jefferies Group Weighs in on Scpharmaceuticals Incs FY2021 Earnings (SCPH)Jefferies Group Weighs in on Scpharmaceuticals Inc's FY2021 Earnings (SCPH)
www.americanbankingnews.com - March 22 at 5:52 PM
Scpharmaceuticals (SCPH) Earns Buy Rating from Jefferies GroupScpharmaceuticals (SCPH) Earns Buy Rating from Jefferies Group
www.americanbankingnews.com - March 21 at 4:00 PM
scPharmaceuticals Inc. Reports Fourth Quarter 2017 Financial ResultsscPharmaceuticals Inc. Reports Fourth Quarter 2017 Financial Results
finance.yahoo.com - March 21 at 8:42 AM
Zacks: Brokerages Anticipate Scpharmaceuticals Inc (SCPH) to Post -$0.53 EPSZacks: Brokerages Anticipate Scpharmaceuticals Inc (SCPH) to Post -$0.53 EPS
www.americanbankingnews.com - March 20 at 11:31 AM
Zacks: Scpharmaceuticals Inc (SCPH) Given $22.33 Average Target Price by BrokeragesZacks: Scpharmaceuticals Inc (SCPH) Given $22.33 Average Target Price by Brokerages
www.americanbankingnews.com - March 19 at 3:22 AM
scPharmaceuticals (SCPH) Presents At 38th Annual Cowen And Company Healthcare Conference - SlideshowscPharmaceuticals (SCPH) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow
seekingalpha.com - March 15 at 6:17 PM
AWM Investment Company Inc. Acquires Shares of 165,100 Scpharmaceuticals Inc (SCPH)AWM Investment Company Inc. Acquires Shares of 165,100 Scpharmaceuticals Inc (SCPH)
www.americanbankingnews.com - March 6 at 4:45 AM
 Brokerages Anticipate Scpharmaceuticals Inc (SCPH) Will Announce Earnings of -$0.53 Per Share Brokerages Anticipate Scpharmaceuticals Inc (SCPH) Will Announce Earnings of -$0.53 Per Share
www.americanbankingnews.com - March 3 at 10:12 AM
Brokerages Anticipate Scpharmaceuticals Inc (SCPH) to Post ($0.53) Earnings Per ShareBrokerages Anticipate Scpharmaceuticals Inc (SCPH) to Post ($0.53) Earnings Per Share
www.americanbankingnews.com - March 3 at 5:28 AM
scPharmaceuticals Inc. to Present at the Cowen 38th Annual Health Care ConferencescPharmaceuticals Inc. to Present at the Cowen 38th Annual Health Care Conference
finance.yahoo.com - March 1 at 8:11 AM
scPharmaceuticals (SCPH) Presents At Leerink Partners 7th Annual Global Healthcare Conference - SlideshowscPharmaceuticals (SCPH) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow
seekingalpha.com - February 16 at 5:20 PM
 Analysts Set $22.33 Target Price for Scpharmaceuticals Inc (SCPH) Analysts Set $22.33 Target Price for Scpharmaceuticals Inc (SCPH)
www.americanbankingnews.com - February 16 at 10:28 AM
ScPharmaceuticals: Time For The PDUFA Run-UpScPharmaceuticals: Time For The PDUFA Run-Up
seekingalpha.com - February 15 at 5:23 PM
Zacks: Analysts Expect Scpharmaceuticals Inc (SCPH) to Post -$0.53 EPSZacks: Analysts Expect Scpharmaceuticals Inc (SCPH) to Post -$0.53 EPS
www.americanbankingnews.com - February 14 at 3:10 PM
Scpharmaceuticals (SCPH) Cut to "Sell" at Zacks Investment ResearchScpharmaceuticals (SCPH) Cut to "Sell" at Zacks Investment Research
www.americanbankingnews.com - February 14 at 1:46 PM
scPharmaceuticals Inc. to Present at the 7th Annual Leerink Partners Global Healthcare ConferencescPharmaceuticals Inc. to Present at the 7th Annual Leerink Partners Global Healthcare Conference
finance.yahoo.com - February 6 at 8:58 AM
Research Analysts Set Expectations for Scpharmaceuticals Incs FY2022 Earnings (SCPH)Research Analysts Set Expectations for Scpharmaceuticals Inc's FY2022 Earnings (SCPH)
www.americanbankingnews.com - January 29 at 8:50 AM
scPharmaceuticals, Inc.s Quiet Period To End  on December 27th (NASDAQ:SCPH)scPharmaceuticals, Inc.'s Quiet Period To End on December 27th (NASDAQ:SCPH)
www.americanbankingnews.com - December 20 at 1:06 AM
BMO Capital Markets Initiates Coverage on scPharmaceuticals (SCPH)BMO Capital Markets Initiates Coverage on scPharmaceuticals (SCPH)
www.americanbankingnews.com - December 18 at 12:56 AM
scPharmaceuticals (SCPH) Coverage Initiated by Analysts at Leerink SwannscPharmaceuticals (SCPH) Coverage Initiated by Analysts at Leerink Swann
www.americanbankingnews.com - December 17 at 10:44 PM
scPharmaceuticals, Inc. (SCPH) Forecasted to Earn FY2017 Earnings of ($2.23) Per SharescPharmaceuticals, Inc. (SCPH) Forecasted to Earn FY2017 Earnings of ($2.23) Per Share
www.americanbankingnews.com - December 14 at 6:50 AM
Research Analysts Offer Predictions for scPharmaceuticals, Inc.s Q3 2017 Earnings (SCPH)Research Analysts Offer Predictions for scPharmaceuticals, Inc.'s Q3 2017 Earnings (SCPH)
www.americanbankingnews.com - December 14 at 6:26 AM
scPharmaceuticals (SCPH) Now Covered by Analysts at Jefferies GroupscPharmaceuticals (SCPH) Now Covered by Analysts at Jefferies Group
www.americanbankingnews.com - December 12 at 9:04 AM
BRIEF-Ra Capital Management Reports 16.2 Percent Passive Stake In ScpharmaceuticalsBRIEF-Ra Capital Management Reports 16.2 Percent Passive Stake In Scpharmaceuticals
www.reuters.com - December 12 at 8:16 AM
scPharmaceuticals Inc. to Present at the BMO Capital Markets Prescriptions for Success Healthcare ConferencescPharmaceuticals Inc. to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
finance.yahoo.com - December 12 at 8:16 AM
scPharmaceuticals Inc. Announces Closing of Over-Allotment Option in its Initial Public OfferingscPharmaceuticals Inc. Announces Closing of Over-Allotment Option in its Initial Public Offering
finance.yahoo.com - December 7 at 7:04 PM
scPharmaceuticals Inc. Announces Closing of Initial Public OfferingscPharmaceuticals Inc. Announces Closing of Initial Public Offering
finance.yahoo.com - November 29 at 8:11 AM
scPharmaceuticals Inc. (SCPH) Major Shareholder Purchases $9,166,668.00 in StockscPharmaceuticals Inc. (SCPH) Major Shareholder Purchases $9,166,668.00 in Stock
www.americanbankingnews.com - November 22 at 4:21 AM
IPO News This Week: A Holiday Break After Another Big WeekIPO News This Week: A Holiday Break After Another Big Week
247wallst.com - November 20 at 9:36 AM
scPharmaceuticals (SCPH) IPO Opens Fractionally Higher - StreetInsider.comscPharmaceuticals (SCPH) IPO Opens Fractionally Higher - StreetInsider.com
www.streetinsider.com - November 19 at 9:08 AM
scPharmaceuticals (SCPH) IPO Opens Fractionally HigherscPharmaceuticals (SCPH) IPO Opens Fractionally Higher
www.streetinsider.com - November 18 at 4:54 AM
scPharmaceuticals Files To Raise $100 Million In U.S. IPOscPharmaceuticals Files To Raise $100 Million In U.S. IPO
seekingalpha.com - November 17 at 8:11 AM
Injectable drug developer scPharmaceuticals prices IPO at $14 low endInjectable drug developer scPharmaceuticals prices IPO at $14 low end
www.nasdaq.com - November 17 at 8:11 AM
Food, Fashion, Finance Firms Among 10 To IPO - BenzingaFood, Fashion, Finance Firms Among 10 To IPO - Benzinga
www.benzinga.com - November 16 at 9:14 AM
scPharmaceuticals (SCPH) Announces November 17th IPOscPharmaceuticals (SCPH) Announces November 17th IPO
www.americanbankingnews.com - November 9 at 1:26 AM

SEC Filings

Scpharmaceuticals (NASDAQ:SCPH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Scpharmaceuticals (NASDAQ:SCPH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Scpharmaceuticals (NASDAQ SCPH) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.